Three different myelin proteins, Nogo, MAG, and OMgp, inhibit regenerating axons after CNS injury. New work reveals that they all share a common receptor and that blockade of this receptor promotes CNS repair and functional recovery. While Nogo has attracted much of the spotlight of late, additional inhibitory myelin proteins are known. One of these, myelin-associated glycoprotein (MAG), shares with Nogo the interesting property that it inhibits postnatal and adult, but not embryonic, neurons. MAG binds to a sialic acid-bearing glycosphingolipid called ganglioside GT1b and closely related gangliosides on the neuronal surface. This ganglioside has been suspected of helping to form a MAG receptor, because clustering of GT1b by antibody complexes is sufficient to inhibit neurite outgrowth by activating a Rho kinase [7, 8] , but it has been unclear how a ganglioside could help to transmit a signal across the plasma membrane. Unexpectedly, the ganglioside GT1b turns out to associate with the neurotrophin receptor p75 to form a MAG receptor complex which transmits an inhibitory signal via the small GTPase Rho [9]. As no inhibitory effect of MAG is seen in the absence of p75, this complex appears to be necessary and sufficient to mediate MAG's inhibitory effects.
consistent with the interactions of these proteins at points of contact between axons and myelin, as well as at synapses [5] . It is unlikely, however, that NgR works alone: its lack of a transmembrane region implies the presence of an as yet unidentified transmembrane coreceptor that transduces the inhibitory signal.
These new findings have already led to efforts to develop drugs that enhance CNS regeneration. By analyzing small peptide fragments of Nogo-66, Strittmatter and colleagues [6] found that, although residues 1-31 of Nogo-66 bind with high affinity to NgR, only a peptide containing residues 31-55 inhibits axon outgrowth. On the basis of these results, they developed a competitive antagonist peptide, termed NEP1-40 for 'Nogo extracellular peptide residues 1-40', which specifically blocks Nogo-66, but not Amino-Nogo, activity [6] . The delivery of NEP1-40 into an injured rat spinal cord produces significant axon regrowth and a modest but noteworthy promotion of locomotor recovery. This finding supports the view that NgR plays an important role in CNS regenerative failure and is an encouraging target for new therapeutics.
While Nogo has attracted much of the spotlight of late, additional inhibitory myelin proteins are known. One of these, myelin-associated glycoprotein (MAG), shares with Nogo the interesting property that it inhibits postnatal and adult, but not embryonic, neurons. MAG binds to a sialic acid-bearing glycosphingolipid called ganglioside GT1b and closely related gangliosides on the neuronal surface. This ganglioside has been suspected of helping to form a MAG receptor, because clustering of GT1b by antibody complexes is sufficient to inhibit neurite outgrowth by activating a Rho kinase [7, 8] , but it has been unclear how a ganglioside could help to transmit a signal across the plasma membrane. Unexpectedly, the ganglioside GT1b turns out to associate with the neurotrophin receptor p75 to form a MAG receptor complex which transmits an inhibitory signal via the small GTPase Rho [9] . As no inhibitory effect of MAG is seen in the absence of p75, this complex appears to be necessary and sufficient to mediate MAG's inhibitory effects.
In striking contrast to this report, a mutant MAG that is unable to bind to gangliosides still inhibits neurite outgrowth when expressed on Schwann cells, implying the presence of an additional MAG receptor [10] . Intriguing new studies have revealed that the Nogo-66 receptor NgR fits the bill and, moreover, is itself necessary and sufficient to mediate MAG's inhibitory actions [11, 12] . These latest findings show that MAG binding to NgR is independent of GT1b, that dominantnegative forms of NgR block MAG activity, and that NgR expression confers both MAG and Nogo-66 responsiveness on embryonic neurons. Importantly, however, the NgR antagonist peptide NEP1-40 does not interfere with MAG's inhibitory activity [12] , suggesting that additional functional recovery may be achieved by improved antagonists.
How can GT1b-p75 and NgR each be necessary and sufficient to mediate MAG's inhibitory effects? The resolution of these seemingly conflicting reports may lie in the propensity of both GPI-anchored proteins and gangliosides to partition into cholesterol-rich microdomains of the cell membrane known as lipid rafts. These are gel-like collections of particular lipids and proteins that float like tiny rafts in the more fluid surrounding membrane. These microdomains can promote signaling by clustering specific proteins together [13] . One possibility is that NgR and GT1b share the ability to cluster and activate the same raft-associated signal transduction apparatus, perhaps p75. Therefore, it will be interesting to see whether Nogo-A directly or indirectly interacts with GT1b and p75, whether inhibition by Nogo-66 requires p75, and whether antibody-mediated clustering of GT1b can still inhibit axon outgrowth in neurons that lack NgR.
Are MAG and Nogo the only inhibitory proteins found in myelin? Recognizing that the myelin sheath is enriched in GPI-anchored proteins [14] , Wang and colleagues [15] searched for GPI-linked proteins from myelin that might be regeneration inhibitors. They enzymatically released all GPI-anchored proteins from purified myelin and found that this fraction contained inhibitory activity. From its molecular weight, they inferred that this activity is oligodendrocyte-myelin glycoprotein (OMgp), a known myelin protein initially isolated from human white matter, and then confirmed that recombinant OMgp is in fact a potent neurite inhibitor. Interestingly, like Nogo, OMgp is also made by neurons [16] . Expression cloning revealed that the binding partner of OMgp is none other than NgR, the same receptor responsible for mediating the inhibitory action of Nogo-66 and MAG. Ectopic NgR expression confers OMgp sensitivity on embryonic neurons. Nogo-66 and OMgp have similar affinities for NgR, bind to overlapping regions, and compete for binding [15] . So, remarkably, three very different myelin proteins inhibit axon regeneration through a common receptor, NgR (Figure 1 
